GHK-Cu

human studyGHK improves tissue repair in skin, lung connective tissue, boney tissue, liver, and stomach lining¹

human studyGHK possesses multiple anti-cancer activities¹

human studyGHK possesses anti-inflammatory actions¹

human studyGHK provides lung protection and restoration of chronic obstructive pulmonary disease (COPD) fibroblasts¹

human studyGHK has anti-anxiety activities¹

human studyGHK has anti-pain activities¹

human studyGHK has anti-aggression activities¹

human studyPlasma GHK levels were decreased in COPD patients compared to healthy controls¹¹

human studyPlasma GHK levels in COPD patients were associated with pectoralis muscle area¹¹

human studyPlasma concentrations of GHK-Cu decline measurably with age: from approximately 200 ng/mL in young adults to roughly 80 ng/mL in older populations¹⁷

human studyIn a 12-week study involving 71 women with mild to advanced signs of photoaging, a facial cream containing GHK-Cu showed significant improvements in skin laxity, clarity, and firmness, and a reduction in the appearance of fine lines and wrinkles¹⁹

human studyGHK-Cu plasma levels fall by over 60% between age 20 and 60²⁰

human studyGHK-Cu plasma level decline tracks closely with measurable declines in skin elasticity, wound repair, and hair follicle function²⁰

human studyGHK-Cu has generated substantial evidence in both clinical cosmetic studies (with human subjects) and preclinical wound-healing research²³

human studyA 2006 controlled trial found no objective benefit for GHK-Cu²⁴

animalGHK's ability to improve tissue repair has been demonstrated for skin, lung connective tissue, boney tissue, liver, and stomach lining²

animalGHK provides lung protection and restoration of chronic obstructive pulmonary disease (COPD) fibroblasts²

animalGHK has anti-anxiety, anti-pain and anti-aggression activities²

animalIn LPS-induced inflammation model in vivo and in vitro, GHK-Cu@CMHA gel reduced levels of inflammatory factors⁶

animalGHK-Cu alleviated weight loss in DSS-induced UC mice⁸

animalGHK-Cu improved the disease activity index (DAI) in DSS-induced UC model⁸

animalGHK-Cu reduced colonic edema and shortening in UC mice⁸

animalGHK-Cu attenuated inflammatory damage in DSS-induced UC⁸

animalGHK-Cu increased goblet cell numbers in UC model⁸

animalGHK-Cu promoted mucosal repair in UC mice⁸

animalGHK-Cu attenuates lung inflammation and fibrosis in silicosis mice¹⁰

animalGHK-Cu has been shown to promote skin remodeling, wound healing and regeneration¹³

animalAt 6 weeks post-ACLR, GHK-Cu groups resulted in a smaller side-to-side difference in knee laxity compared to saline group (p = 0.009)¹⁴

animalNo significant difference in knee laxity at 12 weeks post-operation between GHK-Cu and saline groups¹⁴

animalThe graft complex in the 0.3 mg/ml GHK-Cu group had higher stiffness than saline group at 6 weeks post-operation (p = 0.026)¹⁴

animalNo significant difference in ultimate load, gait parameters, and histological scores among treatment groups¹⁴

animalSpinal cord injury repair in rat studies showing motor function recovery¹⁵

animal60+ animal and in-vitro studies show consistent results across gene expression, wound healing, and anti-inflammatory models²²

animalIntranasal GHK-Cu at 15 mg/kg daily for 2 months showed cognitive benefits in mice²⁹

animalGHK-Cu enhances spatial memory and learning in aged mice²⁹

in vitroGHK possesses multiple anti-cancer activities²

in vitroGHK-Cu showed promise in wound healing and anti-inflammatory effects⁴

in vitroBased on cellular studies, GHK can be considered as an anti-wrinkle ingredient⁹

in vitroGHK-Cu did not significantly affect tyrosinase activity¹²

in vitroGHK-Cu led to elastase inhibition, reducing the rate of elastin degeneration and supporting the structural integrity of the skin¹²

expert opinionGHK-Cu has no clinical data supporting its use for musculoskeletal conditions⁴

expert opinionPreclinical studies on wound-healing peptides like GHK-Cu are promising, but there is a current lack of clinical trials⁵

expert opinionThere is a surprising absence of clinical studies using GHK-Cu and Pal-GHK despite their widespread use in cosmetic products⁹

expert opinionTopical use for skin and wrinkles: moderate evidence — one positive RCT, one negative RCT, several open-label trials¹⁵

expert opinionThe positive diabetic ulcer RCT is unreplicated after 30 years¹⁵

expert opinionNo placebo-controlled wrinkle RCTs exist despite decades of cosmetic use¹⁵

expert opinionTopical GHK-Cu has the most clinical validation; injectable use is based primarily on community protocols and preclinical data¹⁶

expert opinionInjectable GHK-Cu research in humans is sparse¹⁷

expert opinionPromotes skin tightening and wrinkle reduction, with a well-established topical safety profile²¹

expert opinionNo human clinical trials exist for injectable GHK-Cu²²

expert opinionOver five decades of research have established biological activity of GHK-Cu²³

expert opinionNo human clinical trials have examined GHK-Cu for any systemic therapeutic application²³

expert opinionGHK-Cu has more human data than BPC-157 or TB-500 for topical cosmetic applications²³

expert opinionGHK-Cu has essentially no human data for systemic therapeutic use²³

expert opinionNo randomized controlled trials in humans have been conducted for any indication, and all clinical efficacy claims remain preliminary²⁶

expert opinionAll efficacy evidence for GHK-Cu is from animal models or cell culture; no human RCTs exist for any indication²⁶

expert opinionWhen injected — which is how most biohackers use it — there is zero published human data²⁷

expert opinionAll published human efficacy data is from topical application (creams, serums, post-procedure gels). No published human trial has tested subcutaneous or intramuscular injection²⁷

expert opinionAll available evidence for GHK-Cu comes from animal models and in vitro studies²⁹

theoreticalGHK-Cu's injectable dossier is animal-model and in-vitro only, with no human randomized trials²⁴

animalROS levels decreased in response to GHK-Cu@CMHA gel treatment⁶

animalSuperoxide dismutase (SOD) activity was enhanced by GHK-Cu@CMHA gel⁶

animalH&E staining and Masson staining revealed significant collagen deposition with GHK-Cu@CMHA treatment⁶

animalGHK-Cu suppressed inflammatory cytokines TNF-α, IL-6, and IL-1β⁸

animalGHK-Cu upregulated SIRT1 protein expression in colon tissue and MCECs⁸

animalGHK-Cu suppressed phosphorylated p-STAT3 expression in colon tissue and MCECs⁸

animalGHK-Cu could inhibit RORγt expression in colon tissue of UC mice⁸

animalGHK-Cu may promote mucosal healing and enhance tight junction protein expression by regulating the SIRT1/STAT3 pathway⁸

animalGHK-Cu may reduce the number of Th17 cells⁸

animalGHK-Cu acts as a potential drug by attenuating alveolar macrophage oxidative stress, thereby attenuating the progression of pulmonary inflammation and fibrosis¹⁰

animalGHK-Cu protects against cigarette smoking-induced skeletal muscle dysfunction via SIRT1 pathway¹¹

animalGI healing via SIRT1/STAT3 pathway in mouse colitis model¹⁵

animalLung fibrosis protection via PRDX6 targeting¹⁵

animalHair growth via Wnt/β-catenin pathway in mouse model¹⁵

animalStudies in cell culture and animal models suggest GHK-Cu stimulates fibroblast proliferation and collagen synthesis¹⁷

animalStudies in cell culture and animal models suggest GHK-Cu promotes angiogenesis¹⁷

animalStudies in cell culture and animal models suggest GHK-Cu modulates TGF-beta signaling involved in wound contraction¹⁷

animalGHK-Cu is a naturally occurring tripeptide-copper complex with mechanistic evidence supporting anti-inflammatory, antioxidant, and tissue-regenerative properties in animal models and cell culture systems²⁶

animalAnimal studies in zebrafish larvae indicate anti-inflammatory activity against both CuSO₄- and LPS-induced inflammation²⁶

animalMechanistic data point to promotion of angiogenesis, integrin-mediated extracellular matrix remodeling, and fibroblast activation in tissue repair contexts²⁶

animalGHK-Cu serves as a stable copper source that enhances lysyl oxidase (LOX) activation, a key enzyme in collagen crosslinking, in fascia regeneration models²⁶

animalWhen applied topically, preliminary evidence suggests GHK-Cu may enhance collagen and glycosaminoglycan synthesis and support nerve outgrowth and angiogenesis²⁶

animalIn a murine model of ulcerative colitis, mechanistic data point to regulation via the SIRT1/STAT3 signaling pathway²⁶

animalA mouse model of silicosis suggests GHK-Cu may attenuate lung inflammation and fibrosis by targeting peroxiredoxin 6²⁶

animalMany unapproved peptides including GHK-Cu demonstrate favorable tissue repair and metabolic outcomes in animal models²⁸

animalGHK-Cu stimulates collagen synthesis (2× more than non-collagen proteins) and extracellular matrix accumulation²⁹

animalGHK-Cu reduces neuroinflammation markers (MCP-1, nitrotyrosine) in hippocampus²⁹

animalGHK-Cu inhibits NF-κB p65 and p38 MAPK signaling pathways²⁹

in vitroGHK (glycyl-l-histidyl-l-lysine) stimulates blood vessel and nerve outgrowth²

in vitroGHK increases collagen, elastin, and glycosaminoglycan synthesis²

in vitroGHK supports the function of dermal fibroblasts²

in vitroGHK has anti-inflammatory actions²

in vitroGHK suppresses NFκB, a molecule thought to accelerate diseases of aging²

in vitroGHK supports DNA repair²

in vitroGHK activates cell cleansing via the proteasome system²

in vitroThe number of human genes stimulated or suppressed by GHK with a change greater than or equal to 50% is 31.2%²

in vitroGHK-Cu was successfully loaded onto HAPs by electrostatic adsorption⁶

in vitroGHK-Cu exhibits known anti-inflammatory properties⁸

in vitroGHK-Cu facilitated MCECs healing by upregulating ZO-1 and Occludin expression in co-culture model⁸

in vitroGHK-Cu stimulant effect on MCECs healing is canceled after STAT3 silencing by siRNA⁸

in vitroMetal complexation and chemical modification with a hydrophobic moiety increase permeability of GHK peptide⁹

in vitroGHK-Cu can bind to peroxiredoxin 6 (PRDX6)¹⁰

in vitroGHK-Cu inhibits crystalline silica-induced oxidative stress in alveolar macrophages¹⁰

in vitroGHK-Cu rescued CSE-induced skeletal muscle dysfunction in C2C12 myotubes with increased myosin heavy chain expression and reduced MuRF1 and atrogin-1 expression¹¹

in vitroGHK-Cu directly binds and activates SIRT1 with binding energy of -6.1 kcal/mol¹¹

in vitroAnionic and cationic hydrogenated lecithin-based liposomes can be used as GHK-Cu skin delivery systems¹²

in vitroCationic liposomes showed higher bilayer fluidity than anionic liposomes¹²

in vitroGHK-Cu has anti-inflammatory and tissue remodeling properties¹³

in vitroGHK-Cu has prominent antioxidant and anti-inflammatory effects in in vitro and in vivo studies¹³

in vitroGHK affects expression of >4,000 human genes per Broad Institute Connectivity Map analysis — upregulating DNA repair, antioxidant systems, and collagen synthesis while downregulating inflammation, fibrosis, and cellular senescence¹⁵

in vitroGHK-Cu affected the activity of approximately 4,000 genes, roughly 6% of the human genome¹⁶

in vitroGHK-Cu upregulates collagen synthesis genes, DNA repair genes, antioxidant response genes, and stem cell markers¹⁶

in vitroGHK-Cu downregulates inflammatory genes, metastasis-associated genes, and tissue destruction pathways (matrix metalloproteinases)¹⁶

in vitroGHK-Cu promotes the synthesis of collagen types I, III, and V, elastin, decorin, and proteoglycans¹⁶

in vitroGHK-Cu modulates matrix metalloproteinases (MMPs), both activating certain MMPs needed for tissue remodeling and inhibiting excessive MMP activity¹⁶

in vitroStudies in cell culture and animal models suggest GHK-Cu activates superoxide dismutase and other antioxidant pathways¹⁷

in vitroThe copper-binding component appears essential: dephosphorylated or copper-free analogs show substantially reduced activity in most assay models¹⁷

in vitroAt the transcriptome level, GHK-Cu modulates over 4,000 genes in a pattern that mirrors a reversal of the biological aging signature²⁰

in vitroGHK-Cu is a copper chaperone that depends critically on the copper (II) ion it carries, which neutralizes free radical catalysis while delivering bioavailable copper to cuproenzymes²⁰

in vitroGHK-Cu forms a stable 1:1 complex with copper (II) ions²⁰

in vitroGHK-Cu acts as a local tissue copper chaperone, capturing free copper ions during protein breakdown and ferrying them to cells²⁰

in vitroThe copper ion in GHK-Cu neutralizes free copper toxicity via the Fenton reaction²⁰

in vitroGHK-Cu appears to enter cells through interaction with cell surface receptors and activates downstream signaling cascades²⁰

in vitroGHK-Cu affects approximately 32% of tissue-remodeling genes in vitro²²

in vitroThe claim that GHK reprograms more than four thousand genes derives from a single 2014 reanalysis of three cancer-cell-line microarray profiles and has not been independently replicated²⁴

in vitroLoren Pickart isolated the tripeptide from human plasma in 1973 and originally described it as a serum factor that prolonged the survival of cultured liver cells²⁴

in vitroGHK-Cu modulates 4,048 human genes at a concentration of 1 µM according to Campbell and colleagues gene-expression analysis²⁵

in vitroIn vitro evidence indicates antioxidant properties in cell-based systems²⁶

in vitroGHK-Cu inhibits elastase by 48.90% while not significantly affecting tyrosinase²⁹

in vitroGHK-Cu complexes can be formed when Cu ions pass through nanochannels modified with GHK peptide³¹

expert opinionGHK-Cu (glycyl-L-histidyl-L-lysine-Cu(II)) is a well-known activator of tissue remodeling¹⁴

expert opinionGHK-Cu is a naturally occurring copper-binding tripeptide (Gly-His-Lys + Cu²⁺) found in human plasma, released during tissue injury from extracellular matrix protein degradation¹⁵

expert opinionGHK-Cu is an endogenous tripeptide that naturally chelates copper ions and is found in human plasma, saliva, and urine¹⁷

expert opinionGHK-Cu peptide has regenerative, antioxidant, and anti-inflammatory properties¹⁸

expert opinionGHK-Cu is a tripeptide consisting of three amino acids—glycyl-L-histidyl-L-lysine—with a strong affinity for binding to copper ions (Cu2+)¹⁹

expert opinionGHK-Cu has the ability to make old liver cells behave like younger ones¹⁹

expert opinionGHK-Cu can modulate the activity of thousands of human genes, essentially resetting them to a younger, healthier state¹⁹

expert opinionGHK-Cu upregulates genes involved in antioxidant defense, tissue repair, and anti-inflammatory pathways while downregulating genes associated with inflammation and tissue destruction¹⁹

expert opinionGHK-Cu is a potent stimulator of collagen, elastin, glycosaminoglycans, and proteoglycans¹⁹

expert opinionGHK-Cu reduces the levels of key inflammatory cytokines like IL-6¹⁹

expert opinionGHK-Cu promotes the formation of new blood vessels (angiogenesis)¹⁹

expert opinionGHK-Cu helps maintain the health and proliferative potential of stem cells¹⁹

expert opinionGHK-Cu is a naturally occurring peptide-copper complex found in human blood, saliva, and urine²¹

expert opinionDelivers copper ions to activate tissue repair enzymes, stimulate collagen synthesis, and reduce inflammation for wound healing and skin regeneration²¹

expert opinionServes as carrier for copper ions essential for lysyl oxidase (collagen crosslinking) and superoxide dismutase, supporting enzymatic repair processes²¹

expert opinionStimulates synthesis of collagen types I and III, elastin, proteoglycans, and glycosaminoglycans, promoting tissue remodeling²¹

expert opinionAccelerates wound healing through attraction of macrophages and mast cells to injury sites, supporting inflammatory phase resolution²¹

expert opinionIncreases expression of growth factors including VEGF, FGF, and NGF (proposed), which may promote angiogenesis and tissue repair²¹

expert opinionReduces pro-inflammatory cytokines and limits oxidative damage, modulating iron release from ferritin to reduce free radicals²¹

expert opinionMay influence expression of thousands of genes in directions associated with tissue health (proposed), with broad regenerative effects²¹

expert opinionGHK-Cu is a naturally occurring copper tripeptide found in human plasma²²

expert opinionGHK-Cu is found in human plasma, saliva, and urine²²

expert opinionGHK-Cu differs mechanistically from tissue-repair peptides like BPC-157 and TB-500²³

expert opinionGHK-Cu was reframed from a wound-healing peptide to a potential broad-spectrum modulator of gene expression²³

expert opinionGHK-Cu is a tiny molecule made of just three amino acids and a copper atom²⁷

expert opinionYour body produces it naturally, and its levels drop as you age²⁷

expert opinionThe compound was discovered in 1973 by Loren Pickart, who noticed that blood plasma from young people could make liver cells from older people behave like younger tissue²⁷

expert opinionGHK-Cu levels in human blood drop from roughly 200 ng/mL at age 20 to about 80 ng/mL by age 60, a decline that tracks with slower wound healing, thinner skin, and reduced tissue repair²⁷

expert opinionPrimary molecular function includes copper delivery to cells; gene expression modulation (~31% of human genes per Connectivity Map analysis); collagen and decorin synthesis stimulation; anti-inflammatory and antioxidant signaling²⁷

theoreticalGHK-Cu can bind copper(II) ions²

theoreticalGHK-Cu is an endogenous tripeptide–metal complex³

theoreticalGHK-Cu has multifaceted biological roles in tissue repair, anti-inflammatory regulation, extracellular matrix remodeling, and redox homeostasis³

theoreticalKey production technologies include tandem-repeat expression, high-cell-density fermentation, inclusion-body-assisted purification, and Cu(II) complex stabilization³

theoreticalTherapeutic peptides are short-chain amino acids that regulate cellular functions and facilitate biochemical processes⁴

theoreticalGHK-Cu is a wound-healing peptide that promotes angiogenesis, integrin-mediated extracellular matrix remodeling, and fibroblast activation⁵

theoreticalTherapeutic peptides including GHK-Cu modulate molecular signaling networks such as PI3K/Akt, mTOR, MAPK, TGF-β, and AMPK central to tissue regeneration, inflammation resolution, and neuromuscular recovery⁵

theoreticalGHK-Cu occurs naturally in the human body⁷

theoreticalGHK has capability of tissue regeneration and enhancement of collagen and glycosaminoglycans synthesis⁹

theoreticalGHK is able to increase nerve outgrowth and angiogenesis⁹

theoreticalCell penetrating peptides seem promising to increase skin permeation of GHK and its derivatives⁹

theoreticalSkin pretreatment with microneedles has potential to enhance permeation of GHK peptides⁹

theoreticalGHK, a tripeptide naturally occurring in human blood and urine, has antioxidant effects¹⁰

theoreticalGHK is a normal component of human plasma, saliva, and urine¹¹

theoreticalGHK promotes tissue regeneration and acts as anti-inflammatory and antioxidant¹¹

theoreticalGHK has a very high affinity for copper and forms the chelate GHK-Cu¹³

theoreticalGHK-Cu consists of just three amino acids — glycine, histidine, and lysine — complexed with a copper(II) ion¹⁶

theoreticalCopper is a required cofactor for lysyl oxidase, superoxide dismutase (SOD), tyrosinase, and cytochrome c oxidase¹⁶

theoreticalA 2012 gene expression analysis by Pickart and colleagues identified GHK-Cu as influencing the expression of over 4,000 human genes¹⁷

theoreticalGHK-Cu is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine¹⁸

theoreticalGHK-Cu plays a crucial role in maintaining tissue health, supporting collagen production, and activating genes responsible for antioxidant defense and tissue remodeling¹⁸

theoreticalWhen complexed with copper (Cu2+), GHK becomes an active molecule that can influence gene expression, helping regulate collagen and elastin formation, skin and connective tissue regeneration, inflammation reduction, and cellular protection from oxidative stress¹⁸

theoreticalGHK-Cu works as a copper delivery vehicle carrying copper ions to cells and enzymes for repair and maintenance²²

theoreticalGHK-Cu is the copper complex of a three-amino-acid peptide, glycyl-L-histidyl-L-lysine²⁴

theoreticalGHK is studied as a copper-delivery and matrix-signaling peptide²⁴

theoreticalThe Gly-His-Lys sequence occurs as an internal motif within several human proteins, including albumin, the alpha-2 chain of type I collagen, SPARC, and thrombospondin-1²⁴

theoreticalPrimary metabolism occurs via aminopeptidase and carboxypeptidase hydrolysis²⁵

theoreticalCopper is transferred to albumin, then ceruloplasmin for systemic recycling²⁵

theoreticalSerum albumin carries approximately 75% of exchangeable copper in plasma²⁵

theoreticalGHK peptide has robust complexing ability with Cu ions³¹

theoreticalGHK peptide has high affinity for Cu ions³¹

expert opinionGHK-Cu dosing in published research falls into two distinct categories: topical formulation studies and preclinical studies using systemic administration in animal models²³

in vitroGHK-Cu@CMHA exhibits sustained release properties for 7 days⁶

in vitroStable GHK-Cu-loaded liposome systems of small sizes (approx. 100 nm) were obtained¹²

in vitroCopper peptide complexes demonstrated measurable dermal concentrations in ex-vivo human skin models via permeation studies²⁵

in vitroGHK-Cu has limited skin permeation due to its hydrophilic nature; mechanistic data indicate that liposomal encapsulation improves bioavailability in topical delivery contexts²⁶

expert opinionStandard reconstitution of 50 mg vial with 3.0 mL sterile or bacteriostatic water produces a solution with 16.67 mg/mL concentration¹⁸

expert opinionInjectable GHK-Cu lacks formal human pharmacokinetic studies — dosing protocols in current clinical use are extrapolated from animal data, not human trials²⁰

expert opinionHuman pharmacokinetics, dosing, and safety data are entirely absent from the published literature²⁶

theoreticalGHK-Cu is a fairly hydrophilic compound with limited permeation through the lipophilic stratum corneum⁷

theoreticalLiposomes capable of encapsulating GHK-Cu may improve its permeation potential⁷

theoreticalNo published subcutaneous pharmacokinetics of GHK-Cu exist in any species²⁴

theoreticalMolecular weight of GHK-Cu is 403.9 Da (tripeptide plus one Cu²⁺ ion)²⁵

theoreticalEstimated plasma half-life of 0.5 to 1 hour via subcutaneous route²⁵

theoreticalBinding affinity for Cu²⁺ has a dissociation constant of approximately 10⁻¹⁶ M²⁵

theoreticalPeak plasma concentrations estimated within 15 to 30 minutes following subcutaneous injection²⁵

theoreticalSubcutaneous bioavailability estimated in the 80 to 95% range²⁵

theoreticalGHK-Cu has a molecular weight below 500 Da and can potentially cross the stratum corneum²⁵

theoreticalAs a small tripeptide (~403 Da), GHK-Cu is susceptible to rapid proteolytic degradation in plasma²⁷

expert opinionHypersensitivity reactions to the copper component are a potential concern for GHK-Cu²³

expert opinionThere is absence of any published human safety data for injectable GHK-Cu²³

expert opinionThe FDA has flagged injectable GHK-Cu as a high-risk compounding category²³

expert opinionGHK-Cu is an unapproved peptide operating largely outside of regulatory oversight in a parallel gray market²⁸

expert opinionRigorous human safety data for unapproved peptides like GHK-Cu are scarce²⁸

expert opinionThere is potential for serious harm to patients from unapproved peptides like GHK-Cu²⁸

expert opinionNo safety data exists for chronic GHK-Cu administration in humans²⁹

theoreticalGHK-Cu and Pal-GHK formulations encounter challenges due to their hydrophilic nature and instability⁹

theoreticalHuman safety and efficacy of injectable GHK-Cu have not been established²⁴

animalGHK-Cu improved grip strength in CS-exposed mice¹¹

animalPreliminary observations suggest GHK can partially reverse cognitive impairment in aging mice by targeting anti-inflammatory and epigenetic pathways¹³

animalIntra-articular supplementation with GHK-Cu improved graft healing following ACLR in rat, but beneficial effects could not last as treatment discontinued¹⁴

in vitroGHK-Cu@CMHA gel has good flowability and injectability⁶

expert opinionGHK-Cu has evolved from a dermatological bioactive ingredient into a representative model system linking coordination chemistry, peptide bioactivity, and biomanufacturing engineering³

expert opinionGHK-Cu is a naturally occurring tripeptide–copper complex with a research history spanning over 50 years, studied primarily for wound healing, skin aging, and broad gene expression modulation¹⁶

expert opinionGHK-Cu is known for its role in wound healing, skin repair, collagen synthesis, and tissue regeneration¹⁸

expert opinionGHK-Cu is being studied primarily for wound healing, skin regeneration, and anti-aging applications²¹

expert opinionMay stimulate hair growth (proposed), used in cosmetic applications²¹

expert opinionGHK-Cu has a thirty-year life as a registered cosmetic ingredient²⁴

expert opinionGHK-Cu (glycyl-L-histidyl-L-lysine copper) is marketed direct to patients²⁸

expert opinionGHK-Cu exists only in research contexts with no established medical dosing²⁹

expert opinionGHK-Cu has no FDA-approved indications and no established human dosing regimens²⁹

expert opinionTopical cosmetic formulations containing GHK-Cu exist but lack rigorous clinical validation²⁹

theoreticalGHK-Cu displays beneficial properties via reducing fine lines and wrinkles⁷

theoreticalGHK-Cu displays beneficial properties via tightening skin⁷

theoreticalGHK-Cu displays beneficial properties via improving skin elasticity⁷

theoreticalGHK has properties for wound healing and prevention/reduction of wrinkles⁹

theoreticalGHK-Cu is an anti-aging and wound-healing copper-binding peptide¹²

expert opinionGHK-Cu was discovered in 1973 by Dr. Loren Pickart²²

expert opinionGHK-Cu was first isolated from human plasma in 1973 by Loren Pickart²⁵

expert opinionNo formal FDA pharmacokinetic study has been filed for GHK-Cu²⁵

theoreticalGHK-Cu and Pal-GHK are metal complex and palmitoylated derivatives of GHK, respectively⁹

theoreticalGHK-Cu is a tripeptide, three amino acids long (glycyl-L-histidyl-L-lysine)²⁰